HERZLIYA, Israel and CALGARY, Alberta, Dec. 12, 2024 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") ... Read more